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Attention deﬁcit/hyperactivity disorder (ADHD) is a common and highly heritable psychiatric disorder. In
addition, early life environmental factors contribute to the occurrence of ADHD. Recently, DNA
methylation has emerged as a mechanism potentially mediating genetic and environmental effects.
Here, we investigated whether newborn DNA methylation patterns of selected candidate genes
involved in psychiatric disorders or fetal growth are associated with ADHD symptoms in childhood.
Participants were 426 children from a large population based cohort of Dutch national origin. Behavioral
data were obtained at age 6 years with the Child Behavior Checklist. For the current study, 11 regions at 7
different genes were selected. DNA methylation levels of cord blood DNA were measured for the 11
regions combined and for each region separately. We examined the association between DNA methyl-
ation levels at different regions and ADHD symptoms with linear mixed models.
DNA methylation levels were negatively associated with ADHD symptom score in the overall analysis
of all 11 regions. This association was largely explained by associations of DRD4 and 5-HTT regions. Other
candidate genes showed no association between DNA methylation levels and ADHD symptom score.
Associations between DNA methylation levels and ADHD symptom score were attenuated by co-
occurring Oppositional deﬁant disorder and total symptoms.
Lower DNA methylation levels of the 7 genes assessed at birth, were associated with more ADHD
symptoms of the child at 6 years of age. Further studies are needed to conﬁrm our results and to
investigate the possible underlying mechanism.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Attention deﬁcit/hyperactivity disorder (ADHD) is a neuro-
developmental disorder characterised by delayed brain maturationSophia Children’s Hospital,
ox 2060, 3000 CB Rotterdam,
044657.
eier).
All rights reserved.(Shaw et al., 2007 Dec 4). However, the exact underlying mecha-
nism of ADHD is poorly understood. Twin studies have provided
evidence that ADHD has a genetic basis and heritability is esti-
mated to be around 0.76, ranging from around 60 to over 0.95
(Faraone et al., 2005 Jun 1). Despite the high heritability, few def-
inite risk genes have been identiﬁed (Faraone and Mick, 2010 Mar).
The numerous candidate gene studies and several genome wide
association scans have largely been without consistent ﬁndings
(Zhou et al., 2008 Dec 5; Romanos et al., 2008 May). The complex
phenotype, the very polygenic genotype or geneeenvironment
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and molecular genetic studies (Maher and 2008 Nov 6).
Recent studies have demonstrated a possible role of DNA
methylation in schizophrenia, depression and suicidal behavior
(Petronis, 2004; Mill et al., 2008; Autry and Monteggia, 2009).
Epigenetics may represent a mechanism explaining the occurrence
of disease, in particular as a postulated mechanism linking envi-
ronmental risk factors to biological mechanisms (Plazas-Mayorca
and Vrana, 2011 Jan 7). Early onset, heritable neuro-
developmental disorders are candidates for epigenetic research as
neurons are generated early during development. Epidemiological
studies have associated prenatal exposure to adverse environ-
mental factors like smoking (Langley et al., 2005 Dec), toxins (Braun
et al., 2011 Nov) or maternal stress (O’Connor et al., 2002 Jun) with
the risk of ADHD. These observed environmental risk factors exert
an effect mainly during the prenatal or perinatal period, suggesting
that timing of exposure is important for the susceptibility of the
developing brain. Low birth weight, preceded by intrauterine
growth restriction, can be seen as an indicator of a poor prenatal
environment. Low birth weight also elevates the risk of
adverse behavioral outcomes and is a known risk factor for ADHD
(Heinonen et al., 2010).
Against this background, we investigated whether methylation
patterns of neuronal genes observable at birth are associated with
ADHD symptoms at age 6 years. As ADHD is observed more often in
children born small-for-gestational age, we examined whether
prenatal factors inﬂuence the occurrence of ADHD by alterations in
DNA methylation.
DNA methylation patterns were assessed in cord blood to
examine the association with ADHD prospectively. Although
confounding cannot be excluded this design reduces the chance
of reverse causation as it dissects whether differences in DNA
methylation are a cause or a consequence of the disorder. How-
ever, unmeasured prenatal confounding factors cannot be ruled
out.
Because of inaccessibility of brain tissue in living subjects, in the
current study we examined DNA derived from leukocytes. It is
hypothesized that environmental factors impacting the epigenetic
marks in the fetal brain also induce peripheral epigenetic alter-
ations (Talens et al., 2010 Sep). Based on the literature we selected a
few genes, of which variations are assumed to affect nervous
system development and metabolism (glucocorticoid receptor
(NR3C1), methylenetetrahydrofolate-reductase (MTHFR)), presyn-
aptic genes (Dopamine Receptor D4 (DRD4) and serotonin trans-
porter protein (5-HTT)) or fetal growth (insulin-like growth factor 2
(IGF2DMR), H19, potassium channel protein (KCNQ1OT1)).
2. Methods and materials
2.1. Design and study population
This study was embedded in the Generation R Study, an ongoing
population-based birth cohort from fetal life onwards. The Gener-
ation R Study, designed to identify early environmental and genetic
determinants of growth, development and health, has been previ-
ously described in detail (Jaddoe et al., 2012). Assessments with
physical examinations, biological samples and detailed question-
naires were performed.
Participants comprised a subset (n ¼ 540) of the original Gen-
eration R cohort. To reduce the effect of population stratiﬁcation,
the current study was restricted to children of Dutch national
origin, which was based on the country of birth of the parents and
grandparents. Of the selected children, sufﬁcient quantity and
quality of DNA derived from cord blood was available. 448 children
were randomly drawn from the cohort. The sampling strategy wasto use stratiﬁcation with oversampling of children diagnosed with
ADHD (n ¼ 92). This improved power of the analyses and achieve a
more normal distribution of ADHD symptoms, which are highly
right skewed in the general population as most individuals have
relatively few ADHD symptoms and only a minority have high
ADHD symptoms (Supplementary Figs. 1 and 2).
In addition, 100 children with the smallest birth weight for
gestational age (<-1.75 SD) were selected to investigate the role of
prenatal factors in the etiology of ADHD. However, we also ran the
analyses without this sample. In 426 of all selected children, par-
ents provided data on ADHD symptoms by ﬁlling out the Child
Behavior Checklist.
The study has been approved by the Medical Ethics Committee
of the Erasmus Medical Centre, Rotterdam.2.2. Measurements of DNA methylation and genotyping
It is widely recognized that presynaptic genes are the most
important components in the etiology of ADHD (Gizer et al., 2009
Jul). Based on literature, genes were selected on the basis of their
potential involvement in neurotransmitter systems and neuro-
development (Supplemental Table 1). The number of DNA
methylation regions (n ¼ 12) assessed was limited by the total
amount of DNA (500 ng) used. Hence, we chose to determine the
CpG islands of the genes, and selected the middle region or outer
regions per island or the region previously investigated by other
groups: Two regions of the 5-HTT gene were selected from a pub-
lication by Philibert where the relationship with depression
and alcohol dependency has been investigated (Philibert et al.,
2008 Jul 5).
Previously, Wong et al. described epigenetic differences in twins
in the region of the DRD4 gene and one of the regions in the 5-HTT
gene (Wong et al., 2010 Aug 16).
We additionally selected regions of the IGF2DMR and H19 gene
that are implicated in fetal growth. Talens et al. reported about the
variation and stability of DNAmethylation of the IGF2DMR and H19
region (Talens et al., 2010 Sep).
Epigenetic regulation of the NR3C1 has been associated with
childhood abuse (McGowan et al., 2009 Mar). Primers of the other
regions at the KCNQ1OT1, MTHFR and NR3C1 genes were designed
using the online tool of EpiDesigner (epidesigner.com).
For convenience, we described the three regions at 5HTT and
NR3C1 genes as region A, B or C (Supplemental Table 1).
The assessment of the selected region near the gene CCNL1/
LEKR1, implicated in fetal growth, did not succeed due to technical
issues.
Isolated genomic DNA (500 ng) from cord blood samples was
treated with sodium bisulphite for 16 h using the EZ-96 DNA
methylation kit (Shallow) (Zymo Research, Irvine, CA, USA). This
was followed by PCR ampliﬁcation, fragmentation after reverse
transcription and analysis on a mass spectrometer (Sequenom, Inc,
San Diego, USA). This generated mass spectra that were translated
into quantitative DNA methylation levels of different CpG sites by
MassARRAY EpiTYPER Analyzer software (v1.0, build 1.0.6.88
Sequenom, Inc, San Diego, USA).
Samples were randomly divided over bisulphite conversion and
PCR ampliﬁcation batches.
For each individual, the assays were ampliﬁed from the same
bisulphite-treated DNA. All methylation measurements were done
in triplicate from the same bisulphite-treated DNA.
Genotyping was performed for DRD4-48 base pair variable
number tandem repeat (DRD4-48 bp VNTR) and a 44 bp insertion/
deletion segment of the serotonin transporter gene 5-HTT (5-
HTTLPR) as described previously (Luijk et al., 2011 Dec).
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2.3. Assessment of behavioral problems
Wemeasured behavioral problems of the children at six years of
age by using the Child Behavior Checklist (CBCL/1,5-5). The CBCL is
a parent report questionnaire that contains 99 problem items rated
on a 3-point scale: 0 (not true), 1 (somewhat or sometimes true)
and 2 (very true or often true). The 6-item DSM-oriented scale for
ADHD was selected for our analyses since its items were chosen to
closely map onto DSM-IV criteria for ADHD. The items included
“Can’t sit still, restless, or hyperactive,” “Can’t concentrate, can’t pay
attention for long” and “Quickly shifts from one activity to another”.
By summing scores of these selected items, a DSM-Oriented Scale of
Attention-Deﬁcit/Hyperactivity can be computed that has been
used for continuous analyses. Higher scores represent higher
severity. Good reliability and validity have been reported for the
CBCL (Achenbach and Rescorla, 2000). The CBCL in general have
shown to be a robust predictor of clinically-diagnosed ADHD
(Hudziak et al., 2004 Oct).
For sample selection and dichotomous analyses the Diagnostic
Interview Schedule for ChildreneParent version (DISC-P) was used.
The DISC-P is a structured interview with the parents, assessed
during home visits, that deﬁne diagnoses according to the criteria
speciﬁed by the Diagnostic and Statistical Manual of Mental Dis-
orders (4th ed. DSM-IV, APA, 1994). The reliability and validity of
the DISC-P have been reported to be acceptable (Shaffer et al., 2000
Jan).
The DISC was only assessed in a selected risk and control
group of the Generation R study group. For this reason, data from
DISC was available in 116 children (mainly cases) of the current
study population. To maximize the power for analyses we
used CBCL scores as they were present in 426 children. Median
CBCL ADHD symptom score in children that fulﬁlled criteria of
ADHD according to DISC-P was 8.0 (95% CIe7.2; 8.4), and 2.61
(95% CIe2.5; 3.0) in children that did not fulﬁll these criteria
(Supplemental Fig. 3).
2.4. Covariates
Possible determinants of DNA methylation and ADHD were
derived from the literature (Steegers-Theunissen et al., 2009;
McGuinness et al., 2012 Feb; Adkins et al., 2011 Aug; Schroeder
et al, 2011 Dec).
Information on maternal age, education, parity, prenatal
smoking, alcohol use, folic acid supplement use and child national
origin was obtained by questionnaires during pregnancy. Educa-
tional level of the mother was assessed by the highest completed
education and reclassiﬁed into three categories: no or primary,
secundary or higher education. Maternal prenatal smoking and
alcohol use were classiﬁed as ‘no use’, ‘use until pregnancy was
conﬁrmed’ and ‘continued use during pregnancy’. Height and
weight were measured without shoes and heavy clothing; body
mass index was calculated from weight and height (kg/m2). At 20
weeks pregnancy, we measured maternal psychological problems
using the Brief Symptom Inventory (De Beurs, 2004). Child
gender, birth weight, Apgar score one minute after birth, and the
mode of delivery were derived from medical records completed
by midwives and gynecologists. To deﬁne gestational age at birth,
we used fetal biometry measured at the ﬁrst prenatal visit. In
addition of selection of children of Dutch national origin, child
genetic ancestry was determined by principle component ana-
lyses of genome wide association data, as described previously
(Jaddoe et al., 2010 Nov).2.4.1. Statistical analysis
First, we explored whether individual genetic variations may
underlie variation in DNA methylation levels. The 5-HTT and DRD4
gene are characterized by a variable nucleotide repeat that have
been linked to ADHD in childhood (Gizer et al., 2009 Jul; Faraone
et al., 2001 Jul). We examined the association between genetic
variants DRD4-48 bp VNTR and 5-HTTLPR and DNA methylation
levels in the measured regions in the DRD4 and 5-HTT gene. In the
current population, we tested whether these variations are asso-
ciated with ADHD symptoms at age 6 years using linear regression
models.
Primarily, we investigated the association between DNA
methylation and ADHD symptom score. To further explore our re-
sults we repeated the analyses using a dichotomous outcome
deﬁned by a cut-off of 2 on the ADHD symptom scale of the CBCL.
We also examined the association between DNAmethylation levels
and ADHD diagnosis based on DISC-P interview.
In children with ADHD the risk for comorbid psychiatric disor-
ders is high. We tested speciﬁcity for the association between DNA
methylation on ADHD symptoms by adding symptom scores of the
other CBCL syndrome scales and total symptom scores to the
model.
Additionally, to test whether results depended on the sampling
strategy with an oversampling of children born small-for-
gestational age, all analyses were repeated excluding this sample.
DNAmethylation levels were treated as continuous variables. To
approximate normal distribution, variables of DNA methylation
levels were transformed by the square-root. For the analyses, the
triplicate measurements and DNA methylation levels of the sepa-
rate CpG units within a region were treated as clustered variables
and not as a mean.
For an initial overall analysis of methylation and ADHD symp-
tom score, DNAmethylation levels of all CpG units in the 11 regions
together were combined in one analysis. We present the complete
data from all regions selected and chose a hierarchical approach to
reduce the risk of type I error rather than to report selectively. Next
to speciﬁc effects of DNAmethylation, general effects on the level of
DNAmethylation have been described. Besides, the speciﬁc regions
are correlated; a combined analysis increases the power and helps
detect small effects of DNA methylation. Consequently, we have to
be very careful to interpret speciﬁc effects on DNA methylation as
the focus was on the overall effect.
As most CpG units within one region are correlated (except for
5HTT region A, MTHFR and NR3C1, all CpGs within regions assessed
show correlations varying from 0.23 to 0.90 (P < 0.001)), the as-
sociations with DNAmethylation level were calculated using Linear
Mixed Models. Mixed models have the advantage to allow corre-
lated random effects in individuals. Another advantage of this
model is the ability to accommodate missing data points. Further-
more, using mixed models enables adjustment for relevant cova-
riates on the raw data in the samemodel (Burton et al., 1998 Jun 15).
We also stratiﬁed the analysis on DNA methylation levels of
DRD4 and 5-HTT regions by gender, and tested interactions be-
tween gender and ADHD symptoms.
To understand the effect of environmental factors on DNA
methylation twomodels have been used. First, we only adjusted for
bisulphite and PCR batch, child gender, genetic ancestry (principal
components), gestational age at birth and age at assessment of
CBCL. In the fully adjusted model, maternal educational level, age,
parity, body mass index, psychological problems, smoking, folic
acid supplement use, child birth weight and Apgar score were
added. This approach allowed us to evaluate the effect of exposures
during pregnancy as possible explanatory factors behind any
observational effect of methylation on ADHD symptoms
(Supplemental Fig. 4). Analyses of the association of DNA
Table 1
Child and maternal characteristics in the study population.
N¼426
Child characteristics
Gender, % boys 59.6
Birth order, % ﬁrst born 68.9
Birth weight, g (sd) 3430 (580)
Gestational age, wk (sd) 40.2 (1.5)
Apgar score 1 min after birth (sd) 8.6 (1.3)
Mode of delivery, %
Spontaneous vaginal 73.0
Instrumental vaginal 19.6
Caesarean section 7.4
Maternal characteristics
Age (sd) 30.1 (4.7)
Body Mass Index, kg/m2 (sd) 24.3 (4.0)
Educational level, %
Primary 13.5
Secondary 55.3
High 31.1
Psychological symptoms, score, median (95% range) 0.15 (0.00e1.08)
Smoking during pregnancy, %
Never 69.3
Until pregnancy was conﬁrmed 8.8
Continued 21.9
Values represent means (SD) unless otherwise indicated.
N.H. van Mil et al. / Journal of Psychiatric Research 49 (2014) 51e5954methylation of any 5HTT or DRD4 regions with ADHD outcomes
were adjusted for the respective 5HTT or DRD4 genotypes.
All analyses were performed using SPSS software, version 20.0
(IBM-SPSS, Chicago, IL, USA).
3. Results
Characteristics of the children and their mothers in the study
population are presented in Table 1. The childrenwere born after on
average 40.2 (SD¼ 1.5) weeks of pregnancy. Mean birth weight was
3430 (SD ¼ 580) grams. Mothers had a mean age of 30.1 (SD 4.7)
years, 31.1% of the mothers was higher educated and 30.7% smoked
during pregnancy.
Table 2 showed the association between adjacent DRD4-48 bp
VNTR and 5-HTTLPR and DNA methylation levels. Children with
one or two copies of the 7-repeat at the DRD4-48 bp VNTR have
signiﬁcantly lower methylation levels than children without a 7-Table 2
Associations between haploid genotype in candidate genes and DNA methylation.
Crude analyses Adjusted analyses
Beta (95%CI) P-value Beta (95%CI) P-value
DRD4, number
of 7-repeats
(n ¼ 500)
DRD4 region, % methylation
0 (n ¼ 326) ref ref ref ref
1 (n ¼ 158) 3.40
(4.20;-2.60)
<0.001 3.40
(4.20;-2.60)
<0.001
2 (n ¼ 16) 7.10
(9.20;-4.90)
<0.001 6.70
(8.80;-4.60)
<0.001
5-HTT, alleles-type
(n ¼ 512)
Combined 5-HTT regions, % methylation
LL (n ¼ 171) ref ref ref ref
SL (n ¼ 239) 0.23
(0.32; 0.08)
0.25 0.11
(0.32; 0.09)
0.27
SS (n ¼ 102) 0.33
(0.58;-0.08)
0.01 0.33
(0.58;-0.07)
0.01
Beta, 95% conﬁdence intervals and P-values. Analyses are adjusted for bisulphite and
PCR batch, maternal educational level, age, parity, body mass index, psychological
problems, smoking, folic acid supplement use and child gender, genetic ancestry
(principle components), birth weight, Apgar score, gestational age at birth and age at
assessment of CBCL.repeat. Likewise, having a short allele of 5-HTTLPR was also asso-
ciated with lower DNA methylation levels of the measured 5-HTT
regions. In the current population the presence of a short allele of
5-HTTLPR was associated with an increase of ADHD symptoms (per
copy of short allele: b-0.07 95% CIe0.09; 0.05, P < 0.001). DRD4-
48 bp VNTR showed no associationwith ADHD symptom score (per
copy of 7-repeat: b-0.01 95% CIe0.01; 0.04, P ¼ 0.30).
Next, we examined our primary hypothesis of an association
between DNA methylation and ADHD symptom score measured at
age 6 years (Table 3a). The table presents the models fully
adjusted for bisulphite and PCR batch, maternal educational level,
age, parity, body mass index, psychological problems, smoking,
folic acid supplement use, child gender, genetic ancestry (principle
components), birth weight, Apgar score, gestational age at birth
and age at assessment of CBCL. We found a negative relation be-
tween mean DNA methylation in the overall analysis of all regions
measured. Children with higher methylation levels had less ADHD
symptoms. This effect did not change meaningfully after correction
for DRD4-48 bp VNTR and 5-HTTLPR indicating an independent
effect of DNA methylation level ADHD symptom score (b-0.13, 95%
CIe0.22; 0.04, P ¼ 0.01).
In order to identify speciﬁc regions that contribute to the as-
sociation between DNA methylation and ADHD symptoms in the
overall analyses we subsequently explored speciﬁc regions. DNA
methylation of speciﬁc regions that were negatively associated
with ADHD symptom score were 5-HTT region B and DRD4 region.
This direction is in line with the association between the ADHD risk
variants and lower DNA methylation levels. Associations with
KCNQ1OT1 (b-0.34 95% CIe0.63;0.05, P ¼ 0.02) were strongly
attenuated and became non-signiﬁcant after adjustment for
maternal age, parity and educational level (Table 3a). To better
understand the association between DNA methylation and ADHD
symptoms, we repeated the analyses using a dichotomous variable
of ADHD symptom score with a cut-off at 2 of the CBCL. The effects
were consistent and remained signiﬁcant after adjustment for po-
tential confounders (Table 3b). We additionally tested whether any
interaction between child 5HTTLPR genotype and DNAmethylation
predicted ADHD symptoms. There was no interaction effect be-
tween the 5HTTLPR variation and the respective DNA methylation
levels (Methylation 5HTT regions 5HTTLPR: b 8.87 95% CIe
21.97; 4.64, P¼ 0.20) nor between the DRD4 VNTR 7 repeat and the
respective DNA methylation levels on the level of ADHD problems
(Methylation DRD4 region DRD4 VNTR 7 repeat: b2.03 95% CIe
5.20; 1.14, P ¼ 0.21).
To test whether the results depend on the comorbid psychiatric
symptoms, symptom scores of other CBCL syndrome scales and
total symptoms were added to the model. Associations between
DNAmethylation levels and ADHD symptom score were attenuated
by oppositional deﬁant disorder (ODD) and total symptoms (overall
regions: b-0.10 95% CIe0.22; 0.03, P ¼ 0.12 and b-0.08 95% CIe0.21;
0.06, P ¼ 0.28 respectively). In contrast, the association between
child DNA methylation level and ADHD symptoms could not be
explained by internalizing, affective disorder, anxiety or pervasive
developmental disorder (PDD) problem scale (results not shown).
Analyses of the associations between mean DNA methylation in
cord blood and child ADHD diagnosis based on DISC-P showed no
associations (overall analyses b0.03 95% CIe0.17; 0.24, P ¼ 0.77,
other results not shown).
Next, we examined whether alterations in DNA methylation
associated with ADHD symptoms, were inﬂuenced by prenatal
environmental factors. To this aim, we also studied the associations
without adjustment for indicators of maternal risks during preg-
nancy, including maternal educational level, age, parity, body mass
index, psychological problems, smoking, folic acid supplement use,
child birth weight and Apgar score. Results without adjustment for
Table 3
(a). DNA methylation and ADHD symptom score. (b). DNA methylation and ADHD dichotomous symptom score.
(a) N ¼ 426 Overall methylation
ADHD,
symptom score (sqrt transformed)
All genes jointly analyzed, methylation %
b(95% CI) P-value
0.12 (0.21;-0.02) 0.02
Neurotransmitter systems
ADHD,
symptom score (sqrt transformed)
DRD4, methylation % 5-HTT region A, methylation % 5-HTT region B, methylation % 5-HTT region C, methylation %
b(95% CI) P-value b(95% CI) P-value b(95% CI) P-value b(95% CI) P-value
0.52 (1.00;-0.05) 0.03 0.00 (0.15; 0.15) 1.00 0.22 (0.38;-0.06) 0.006 0.09 (0.26; 0.08) 0.30
Metabolism
ADHD,
symptom score (sqrt transformed)
NR3C1 region A, methylation % NR3C1 region B, methylation % NR3C1 region C, methylation % MTHFR5, methylation %
b(95% CI) P-value b(95% CI) P-value b(95% CI) P-value b(95% CI) P-value
0.03 (0.13; 0.06) 0.45 0.08 (0.20; 0.40) 0.18 0.03 (0.08; 0.14) 0.56 0.05 (0.04; 0.13) 0.28
Fetal growth
ADHD,
symptom score (sqrt transformed)
H19, methylation % IGF2DMR, methylation % KCNQ1OT1, methylation %
b(95% CI) P-value b(95% CI) P-value b(95% CI) P-value
0.07 (0.33; 0.20) 0.62 0.05 (0.30; 0.41) 0.77 0.29 (0.61; 0.02) 0.07
(b) N ¼ 426 Overall methylation
ADHD, symptom score (>2) dichotomous All genes jointly analyzed, methylation %
b(95% CI) P-value
0.25 (0.43;-0.06) 0.009
Neurotransmitter systems
ADHD, symptom score (>2) dichotomous DRD4, methylation % 5-HTT region A, methylation % 5-HTT region B, methylation % 5-HTT region C, methylation %
b(95% CI) P-value b(95% CI) P-value b(95% CI) P-value b(95% CI) P-value
1.04 (2.03;-0.48) 0.04 0.07 (0.37; 0.22) 0.63 0.35 (0.66;-0.03) 0.03 0.07 (0.40; 0.26) 0.68
Metabolism
ADHD, symptom score (>2) dichotomous NR3C1 region A, methylation % NR3C1 region B, methylation % NR3C1 region C, methylation % MTHFR5, methylation %
b(95% CI) P-value b(95% CI) P-value b(95% CI) P-value b(95% CI) P-value
0.11 (0.29; 0.07) 0.22 0.10 (0.34; 0.15) 0.44 0.03 (0.19; 0.25) 0.78 0.07 (0.10; 0.24) 0.44
Fetal growth
ADHD, symptom score (>2) dichotomous H19, methylation % IGF2DMR, methylation % KCNQ1OT1, methylation %
b(95% CI) P-value b(95% CI) P-value b(95% CI) P-value
0.20 (0.73; 0.33) 0.46 0.15 (0.55; 0.85) 0.68 0.50 (1.11; 0.12) 0.11
The beta represent the change in methylation % per squareroot (sqrt) transformed ADHD symptom score as analysed with linear mixed models.
Analyses are adjusted for bisulphite and PCR batch, maternal educational level, age, parity, body mass index, psychological problems, smoking, folic acid supplement use and child gender, genetic ancestry (principle com-
ponents), birth weight, Apgar score, gestational age at birth and age at assessment of CBCL. Analyses of DRD4 and 5-HTT regions are also adjusted for variable number tandem repeats.
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covariates change the effect estimates substantially. This indicates
that adverse prenatal environmental factors do not explain the
association between child DNA methylation and ADHD symptoms.
The only covariates related to both DNA methylation and ADHD
symptoms were genetic ancestry (principle components) and
gender.
When analyses were stratiﬁed by gender, the association be-
tween DNA methylation of all regions measured and ADHD
symptom score was not meaningful different. There was no inter-
action effect of gender (P-value for interaction 0.56).
When analyses were repeated with exclusion of children born
small-for-gestational age, the associations between DNA methyl-
ation level and ADHD symptoms were very similar, however, some
associations were not signiﬁcant as the group size was smaller
(Supplemental Table 2).
4. Discussion
In this studywe investigated the association of DNAmethylation
levels of neuronal and non-neuronal candidate genes with ADHD
symptoms in childhood.
In an overall analysis across 11 regions, lower DNA methylation
levels were associated with higher ADHD symptom scores. The
results were independent of two selected DNA variants. However,
we cannot rule out that other genetic variations in the vicinity of
this region could directly inﬂuence DNA methylation measure-
ments. The effect was largely explained by associations with DNA
methylation levels in DRD4 and 5-HTT regions. However, this result
should be interpreted with caution since our study had insufﬁcient
power to stringently correct for multiple testing in individual re-
gions analyses.
DNA methylation was measured in cord blood collected directly
after birth before any postnatal environmental inﬂuences exerted
an effect. This created a unique opportunity to observe DNA
methylation at baseline and investigate associations with ADHD in
a prospective manner. However, since DNA methylation may be
inﬂuenced by a variety of postnatal factors such as social environ-
ment, environmental toxins and drugs, this does not rule out
environmental effects (Weaver et al., 2004 Aug; Rampon et al.,
2000 Nov 7; Bollati et al., 2007 Feb 1; Cheng et al., 2008 Mar).
Several explanations may help to clarify the associations be-
tween lower levels of DNAmethylation andmore ADHD symptoms.
First of all, this association could be inﬂuenced by other con-
founding factors that might be in the causal pathway of environ-
mental factors inﬂuencing the epigenome. We corrected our
analysis for numerous potential confounding factors, however,
there is little information from literature on what variables to
control for.
Second, genetic factors could underlie the association between
DNA methylation and ADHD symptoms. We corrected for the child
genetic variables in the selected regions. In this study we reported
lower DNA methylation levels in subjects with the risk allele of the
DRD4-48 bp VNTR or the 5-HTTLPR polymorphism. The association
between low DNA methylation levels of DRD4 and 5-HTT regions
was largely independent of the genetic variants DRD4-48 bp VNTR
or 5-HTTLPR. In previous studies, the presence of the DRD4-48 bp
VNTR was shown to affect mRNA expression in vitro (Schoots and
Van Tol, 2003). However, we did not take into account other ge-
netic variations than those two sites assessed, although several
other polymorphisms exist in these regions.
Proper DNA methylation plays a critical role in embryonic
development and cell differentiation. Methylation also plays a
mediating role in gene expression (Suzuki and Bird, 2008 Jun).
Although there is no simple relationship between DNAmethylation and gene expression it is assumed that DNA
methylation is associated with loss of gene expression (Reik and
2007 May 24). In reports of patients with psychiatric disorders,
e.g. bipolar disorder, schizophrenia, anorexia nervosa and DNA
methylation, patients were more likely to have hypomethylated
(neuronal) candidate genes (Frieling et al., 2007; Abdolmaleky et
al., 2006). This is in line with our study, where we report a
negative association between DNA methylation levels and ADHD
symptoms.
The selection of our candidate genes was based on previous
psychiatric epigenetic and candidate gene studies. It is postulated
that ADHD may be caused by an imbalance of neurotransmitters
(Russell et al., 2000 Dec 20). Research has focused in particular on
the dopaminergic system, since effective medication was reported
to block the reuptake of dopamine by the dopamine transporter
molecule (Krause et al., 2000 May 12). Early reports of animal
models of ADHD resembling the human condition demonstrated
increased DRD4 expression (Zhang et al., 2002 May; Zhang et al.,
2001 Nov).
A study by Wang et al. suggests that peripheral DNA methyl-
ation of the serotonin transporter may be a marker of central se-
rotonin transporter function (Wang et al., 2012). However, a meta-
analyses of Gizer et al. indicated a modest but signiﬁcant associa-
tion between ADHD and the 5HTTLPR “long allele” (Gizer et al.,
2009 Jul).
In mice, prenatal protein restriction leading to intrauterine
growth retardation, signiﬁcantly increased expressed dopamine
related genes (Vucetic et al., 2010 Jun 30). However, in the current
study the association between DNA methylation and ADHD
symptoms was independent of birth weight. Possibly, although we
corrected for many environmental factors, prenatal inﬂuences not
reﬂected by changes in birth weight may underlie these behavioral
symptoms.
In this studywe did not observe any association between ADHD-
associated prenatal exposures and child DNA methylation at birth.
The observed effects are rather small, this makes it difﬁcult to
reveal a mediation by DNA methylation on the risk of ADHD
symptoms. On the other hand, since no previous human study has
succeed to link disease-associated exposures via DNA methylation
to the occurrence of disease, it might be the case that both envi-
ronmental exposure and DNA methylation have largely indepen-
dent effects.
The association between DNA methylation patterns and ADHD
diagnose based on DISC and CBCL ADHD symptom score show
different results. An important explanation might be that using
CBCL symptoms increases power as a symptom count was available
in more children in the analyses and analysed continuously.
Second, there could be discrepancies in item speciﬁcity between
the DISC and the CBCL instrument. Although the clinical utility of
categorically deﬁned ADHD is well established, there is also strong
evidence that the liability to develop ADHD problems is continuous.
Clustering of subjects in terms of subtypes, as DISC does, neglects
variation in severity as childrenwithmoderately elevated symptom
scores on several subtypes won’t meet DSM-IV criteria for ADHD
while children with elevated symptom scores on one subtype will
(Hudziak et al., 2004 Oct).
As ADHD is known to have high psychiatric comorbidity, al-
terations in DNA methylation might be the result of other dis-
orders. Alterations in DNA methylation are reported to play a role
in the aetiology of bipolar disorder, autism and obsessive
compulsive disorder, among others (Seeman et al., 1993 Sep 30;
Melnyk et al., 2012 Mar; Zill et al., 2012). In the current study,
sensitivity analyses showed that ODD and total symptom scores
attenuated the association between DNA methylation levels and
ADHD symptom score. This suggests that the observed
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ﬂects our choice of candidate gene sites for the methylation
analyses. All psychiatric genes have been implicated in several
developmental disorders, and candidate genes speciﬁcally
related to ADHD have not been identiﬁed.
At the same time, the association between lower DNA methyl-
ation and more ADHD symptoms was independent of internalizing
symptoms. This ﬁnding is in line with the observations from Ken-
dler et al., that internalizing and externalizing disorders originate
partly from different genetic mechanisms (Kendler et al., 2011 Jan;
Kendler et al., 2003 Sep), whereas symptoms of ADHD and
aggression are not only frequently co-morbid reﬂecting a more
substantially shared genetic vulnerability (Hamshere et al., 2013
Aug 1). However, we have to be careful to translate ﬁndings in
genetic studies to epigenetics and can only speculate about the
parallels between underlying genetic and epigenetic structures in
psychiatric disorders.
Epigenetics provide a possible mechanism for geneeenviron-
ment interactions that have been observed in ADHD (Thapar et al.,
2007 Jan). Several models postulating a complex interplay between
the genome, epigenome and environmental factors have been
proposed. Some speciﬁc tandem repeats are associated with alter-
ations in epigenetic patterns (Bell et al., 2010). Other possibilities
are an increased susceptibility by genetic variations for environ-
mental factors to alter DNA methylation or, vice versa, an increased
susceptibility for geneeenvironment interactions in the presence of
altered DNA methylation. In the current study, we describe that
DRD4-48 bp VNTR and 5-HTTLPR were associated with lower DNA
methylation levels of the adjacent regions. The alterations in DNA
methylation could be the result of interaction effects instead of
direct genetic effects. However, testing interaction effects was not
the core aim of the current study as we lacked hypotheses and,
besides, sufﬁcient power.
Several limitations of our study should be mentioned. First, in
the current study attention problems were primarily assessed by
means of a structured questionnaire and attention problems were
considered as a continuous trait instead of a dichotomy. This has
been shown to adequately represent attention problems on the
population level and provides more power in the analyses. Further,
the CBCL-ADHD symptom scale converges with the results of
clinical interviews covering the DSM-IV-criteria (Biederman et al.,
1993 Oct).
Second, our focus on selected regions in the genome made it
unable to extrapolate our ﬁndings to other genomic regions. We
performed an overall analysis of all regions assessed under the
assumption that the variation of methylation has a uniform direc-
tion of effect. Separate analyses of the speciﬁc regions showed
certain heterogeneity of effects across the different genomic re-
gions, however, the direction of methylation effects at birth on
ADHD symptoms was consistent.
Third, the DNA in the current study was isolated from leu-
kocytes and not from brain tissue. The question rises how al-
terations in DNA methylation proﬁles in cord blood reﬂect DNA
methylation proﬁles in other tissue of the child. This is a major
problem in human studies. One post-mortem study analyzed an
average of approximately 1500 regions, from 12 different tissues
from different brain parts and other organs obtained from adult
individuals found that only 34 CpGs were differently methylated
among neural and non-neuronal tissues (Ghosh et al., 2010 Aug
16). Another study analyzing DNA methylation variation across
brain and blood found that, although between-tissue variation
exceed between-individual variation, inter-individual variation
was reﬂected across brain and blood. This implies that peripheral
tissues may be of use for epidemiological studies (Davies et al.,
2012). Talens et al., reported for four of the eight investigatedregions strong correlations between DNA methylation proﬁles in
blood and buccal cells, tissues from different germ layers (Talens
et al., 2010 Sep). However, no studies have compared fetal brain
and peripheral tissues.
Finally, our study relied on genomic DNA extracted from whole
blood. Epigenetic differences across samples could be derived from
different cellular leukocyte populations, although cellular hetero-
geneity is considered to have limited impact (Talens et al., 2010
Sep).
To conclude, consistent with the epigenetic hypothesis of ADHD,
a number of regions were found in which lower methylation levels
measured at birth were associated with more ADHD symptoms in
childhood. However, we cannot distinguish whether genetic, non-
genetic intragenerational transmission, or unknown environ-
mental factors underlie this association. Moreover, the observed
association with ADHD symptoms was partly explained by co-
occurring ODD and total symptoms. Further studies are needed to
conﬁrm our results and to investigate the possible underlying
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